By Editorial Staff
October 13, 2025
The words “You have cancer” are arguably the most jarring phrase a human being can hear. Yet, for Miriam Sabo, the diagnosis that shattered her world at age 42 was far more specific and devastating: “You have Stage 4 Breast Cancer.”
Sabo’s story is not one of a traditional “battle” or a search for a “cure” in the conventional sense. Instead, it is a testament to the resilience of the human spirit when faced with a non-curative, life-altering reality. As a member of the approximately 6% of breast cancer patients diagnosed with de novo metastatic breast cancer (MBC)—meaning the disease had already spread to other parts of the body, in her case the liver, at the time of the initial diagnosis—Sabo represents a unique, often overlooked demographic in the oncology community.
The Reality of De Novo Metastatic Breast Cancer
Metastatic breast cancer, also known as Stage IV, occurs when cancer cells spread from the original tumor in the breast to other parts of the body, most commonly the bones, liver, lungs, or brain. When a patient is diagnosed with de novo MBC, it means the cancer has progressed to this stage before the patient was even aware of its presence.
For many, the initial diagnosis brings a deluge of conflicting emotions: fear, anger, and a desperate search for answers. Sabo notes that while society often frames cancer through the lens of “fighting” and “winning,” that narrative felt hollow to her.
“I personally try to stay away from the word terminal and prefer non-curative,” Sabo explains. “The image of fighter gloves and slogans of ‘we’re gonna beat this’ were not going to be my narrative. Rather, it’s explaining that I’ll be in treatment forever—however long my forever is going to be.”
The Peril of the Internet
One of the most common pieces of advice given to newly diagnosed patients is to avoid “Googling” their condition. Sabo echoes this sentiment with conviction. Statistical data regarding Stage IV cancer—often presented as cold, median survival rates—can be soul-crushing and rarely accounts for the individual advancements in precision medicine, patient resilience, and the evolving nature of treatment protocols. By focusing on the statistics, patients often forfeit their agency to the numbers rather than focusing on the quality of their current reality.
A Chronology of Resilience: 6.5 Years and Counting
The journey of a metastatic patient is not linear. It is a marathon marked by constant monitoring, periodic treatment adjustments, and the integration of medical care into every aspect of daily life.
The Initial Shock
When Sabo was diagnosed 6.5 years ago, the initial months were characterized by a frantic need for clarity. Having previously interacted with Sharsheret, a national organization supporting Jewish women and families facing breast cancer, she knew where to turn. Years prior, she had reached out regarding BRCA genetic testing; though she tested negative, the foundation of trust was already built.
Building the Support System
Sabo describes her relationship with the organization as instrumental in her survival. She was paired with a social worker, Rachel, who became a vital sounding board for the existential weight of her diagnosis. Beyond individual support, the organization’s "Embrace" program, led by Bonnie, provided a community of peers. Encouraged by these mentors, Sabo transitioned from a recipient of care to a peer supporter, providing guidance to other women navigating the same isolating path of MBC.
Milestones in the Face of Uncertainty
In the years since her diagnosis, Sabo has defied the initial prognostic projections. She has witnessed her four children grow, attended their graduations, and celebrated the marriages of two of her children. These are not merely milestones; they are the result of a conscious decision to live fully despite the presence of a chronic, non-curative illness.
“I was told when I was diagnosed that I’m not milk; there’s no expiration date stamped on me,” Sabo says. This mantra has sustained her through over half a decade of continuous treatment.
Supporting Data and Medical Context
To understand the scope of Sabo’s experience, one must look at the broader landscape of metastatic breast cancer. According to the American Cancer Society and the National Breast Cancer Foundation, while mortality rates for early-stage breast cancer have declined due to improved screening and treatment, metastatic breast cancer remains a leading cause of cancer-related death in women.
Advances in Care
The standard of care for MBC has evolved significantly. While it remains incurable, it is increasingly treated as a chronic condition rather than an acute one. Modern oncology employs:
- Targeted Therapies: Drugs designed to attack specific proteins or mutations on cancer cells.
- Immunotherapy: Boosting the body’s own immune system to recognize and attack malignant cells.
- Endocrine Therapies: Used for hormone-receptor-positive cancers to slow or stop the growth of cells.
These advancements allow many women to live with high quality of life for years, though the burden of “treatment forever” remains a psychological and physical hurdle that requires robust psychosocial support, such as that provided by organizations like Sharsheret.
Official Responses and Psychosocial Implications
Experts in oncology social work emphasize that the psychological impact of a de novo diagnosis is distinct from those who experience a recurrence. There is no period of "clearance" or the illusion of being "cured" to lose.
“The trauma of a de novo diagnosis is immediate,” says a representative from a leading oncology support network. “Patients are forced to reconcile their identity as a healthy person with the reality of a chronic illness simultaneously. Support systems that provide peer mentorship, like the Embrace program, are critical because they shift the focus from medical pathology to the lived experience of survivorship.”
The Role of Faith and Hope
For Sabo, the intersection of medical treatment and spiritual faith is the final pillar of her support system. “I hold onto my faith that G-d’s plans are always for good, even in the hardest of moments,” she says. This perspective provides a framework that transcends medical prognosis. For many patients, the ability to find meaning—whether through faith, family, or community advocacy—is as essential as the chemotherapy or targeted drugs they receive.
Looking Forward: The Future of MBC Advocacy
The narrative of "living with" rather than "dying from" cancer is shifting the paradigm of patient advocacy. There is an increasing demand for:
- Increased Research Funding: A larger percentage of breast cancer research funding is being funneled into metastatic disease rather than just early detection.
- Mental Health Integration: Standardizing psychosocial support as a core component of oncology care, rather than an optional resource.
- Peer-Led Initiatives: Recognizing the unique power of "patient-to-patient" support networks in reducing the feelings of isolation and hopelessness.
As Miriam Sabo continues her journey, her story serves as a reminder to the medical community and the public alike: a diagnosis of metastatic breast cancer is not the end of a life, but the beginning of a complex, challenging, and often profound new chapter. By rejecting the "expiration date" mentality, she embodies the power of human agency in the face of insurmountable odds.
For those currently navigating a similar diagnosis, the message is clear: You are not a statistic. You are a person whose life—and the moments within it—remains your own to define, regardless of the treatment regimen required to sustain it.
About the Author
